Latest Finance News

Neurizon Therapeutics has locked in a $6 million cash rebate from the Australian Government’s R&D Tax Incentive, underpinning its upcoming HEALEY ALS Platform Trial with first patient dosing slated for early 2026.

ASF Group Limited closed December 2025 with $1.91 million in cash and nearly four quarters of funding runway, while progressing key investments in mining, technology, and biotech sectors.

KALiNA Power has strengthened its financial position by selling a 180 MW load allocation for C$18 million, while advancing its Alberta gas-fired power projects amid evolving regulatory frameworks.

NT Minerals Limited reported a mixed cash flow quarter ending December 2025, with ongoing operational losses offset by strong investing inflows and a solid funding buffer. The company signals confidence in continuing operations despite tight liquidity.

Energy Technologies Limited has significantly improved its cash flow position in the December 2025 quarter, reducing cash outflows by over a third while raising additional debt funding to support working capital.

Assetora Limited has strengthened its financial footing by securing over $4 million in capital commitments and resolving all legacy administration matters, positioning itself for a potential ASX reinstatement.

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Group One Capital Limited has reported a remarkable 246% increase in revenue for the half-year ending December 2025, alongside expanding its structured funding facilities beyond $240 million through its subsidiary FSU Capital.

Janus Electric has inked a strategic partnership with a Canadian consortium to deploy swappable battery electric trucks powered by innovative negative-carbon energy, aiming to revolutionise long-haul freight electrification.

Wellnex Life reports a significant turnaround with a 31.5% revenue increase and near break-even operating cash flow in the December quarter, driven by strategic brand consolidation and cost discipline.

Alpha HPA Limited reports strong progress on its HPA First Project Stage 2 construction and secures binding supply contracts for 2026 in the booming semiconductor sector, while launching a $225 million equity raise to fund expansion.

Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.